Error: Could not add to watchlist. X

Nivalis Therapeutics Inc

+ Watchlist
34L:GR
Frankfurt
Price not available for 34L:GR
EUR
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding (m)
14.627
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Nivalis Therapeutics, Inc. operates as a clinical stage pharmaceutical company. The Company focuses on developing a portfolio of small molecule therapeutics for the treatment of major diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, and certain cardiovascular disorders.
ADDRESS
3122 Sterling Circle
Suite 200
Boulder, CO 80301
United States
PHONE
1-720-945-7700
  • Jon Congleton
    President/CEO
  • R Michael Carruthers
    CFO/Secretary
  • Janice M Troha
    Chief Operating Officer
  • Steven A Shoemaker
    VP:Clinical Research
  • Sherif Gabriel
    VP:Research
Show More